1. Home
  2. CKX vs LPCN Comparison

CKX vs LPCN Comparison

Compare CKX & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CKX Lands Inc.

CKX

CKX Lands Inc.

N/A

Current Price

$15.86

Market Cap

21.4M

Sector

Energy

ML Signal

N/A

Logo Lipocine Inc.

LPCN

Lipocine Inc.

N/A

Current Price

$1.69

Market Cap

18.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CKX
LPCN
Founded
1930
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.4M
18.7M
IPO Year
1996
2011

Fundamental Metrics

Financial Performance
Metric
CKX
LPCN
Price
$15.86
$1.69
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $5.00
AVG Volume (30 Days)
★ 476.1K
212.9K
Earning Date
11-24-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 1125.00
N/A
EPS
★ 0.09
N/A
Revenue
$838,543.00
★ $1,976,677.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$18.02
P/E Ratio
$178.06
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$8.66
$1.36
52 Week High
$24.74
$12.37

Technical Indicators

Market Signals
Indicator
CKX
LPCN
Relative Strength Index (RSI) 70.02 52.99
Support Level $10.04 $1.36
Resistance Level N/A $2.30
Average True Range (ATR) 1.44 0.11
MACD 0.62 0.04
Stochastic Oscillator 37.93 84.62

Price Performance

Historical Comparison
CKX
LPCN

About CKX CKX Lands Inc.

CKX Lands Inc is a Louisiana corporation organized to receive non-producing mineral royalties spun off by a southwest Louisiana bank. It operates in three segments: Oil and Gas, Surface, and Timber. The company owns land and mineral interests and collects income through its ownership of oil and gas royalties, surface leases for farming, the right of way, and other uses, and timber sales. The company's oil and gas royalties are paid by the operators who own the wells, and timber income is paid by the highest bidder for the timber. It has small royalty interests in approximately 20 different producing oil and gas fields. Maximum revenue for the company is generated from the Timber segment.

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates, or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy (TRT). It also has other products in the pipeline, such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Share on Social Networks: